Gerald P. Bodey

1.4k total citations · 1 hit paper
14 papers, 1.0k citations indexed

About

Gerald P. Bodey is a scholar working on Oncology, Epidemiology and Molecular Medicine. According to data from OpenAlex, Gerald P. Bodey has authored 14 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Epidemiology and 5 papers in Molecular Medicine. Recurrent topics in Gerald P. Bodey's work include Neutropenia and Cancer Infections (9 papers), Antibiotic Resistance in Bacteria (5 papers) and Fungal Infections and Studies (4 papers). Gerald P. Bodey is often cited by papers focused on Neutropenia and Cancer Infections (9 papers), Antibiotic Resistance in Bacteria (5 papers) and Fungal Infections and Studies (4 papers). Gerald P. Bodey collaborates with scholars based in United States and Canada. Gerald P. Bodey's co-authors include Kenneth V. I. Rolston, John E. Edwards, Ronald Feld, Lowell S. Young, Arthur E. Brown, Donald Armstrong, Jerry L. Shenep, Philip A. Pizzo, Walter T. Hughes and Elias Anaissie and has published in prestigious journals such as Biomaterials, Cancer and Clinical Infectious Diseases.

In The Last Decade

Gerald P. Bodey

14 papers receiving 975 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever

1997 503 citations Walter T. Hughes, Donald Armstrong et al. Clinical Infectious Diseases profile →

Peers

Countries citing papers authored by Gerald P. Bodey

Since Specialization

Citations

This map shows the geographic impact of Gerald P. Bodey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald P. Bodey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald P. Bodey more than expected).

Fields of papers citing papers by Gerald P. Bodey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald P. Bodey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald P. Bodey. The network helps show where Gerald P. Bodey may publish in the future.

Co-authorship network of co-authors of Gerald P. Bodey

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald P. Bodey. A scholar is included among the top collaborators of Gerald P. Bodey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald P. Bodey. Gerald P. Bodey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Prospective, double-blind, randomized trial of teicoplanin versus vancomycin for the therapy of vascular access-associated bacteremia caused by gram-positive pathogens 1999 ·Journal of Infection and Chemotherapy ·Kenneth Rolston, Gerald P. Bodey, Anthony W. Chow	8
2	1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever breakdown → 1997 ·Clinical Infectious Diseases ·Walter T. Hughes, Donald Armstrong, Gerald P. Bodey, Arthur E. Brown, John E. Edwards, Ronald Feld, Philip A. Pizzo, Kenneth V. I. Rolston, Jerry L. Shenep, Lowell S. Young	503
3	A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients 1996 ·Cancer ·Issam Raad, Estella Whimbey, Kenneth Rolston, Dima Abi-Said, Ray Hachem, (unknown), Habib M. Ghaddar, (unknown), Gerald P. Bodey	37
4	Survey of Antibiotic Susceptibility among Gram-Negative Bacilli at a Cancer Center 1996 ·Chemotherapy ·Kenneth Rolston, Linda S. Elting, Steven G. Waguespack, D H Ho, Barbara LeBlanc, Gerald P. Bodey	10
5	Fluconazole versus Amphotericin B in the treatment of Hematogenous Candidiasis: A matched cohort study 1996 ·The American Journal of Medicine ·Elias Anaissie, S. E. Vartivarian, Dima Abi-Said, Ömrüm Uzun, Hélio Pinczowski, (unknown), (unknown), Kostas Papadakis, Alison Gardner, Issam Raad, (unknown), Gerald P. Bodey	142
6	In vitro antimicrobial efficacy of silver iontophoretic catheter 1996 ·Biomaterials ·I. Raad, Ray Hachem, (unknown), (unknown), Gerald P. Bodey	36
7	DERMATOLOGIC MANIFESTATIONS OF INFECTIONS IN NEUTROPENIC PATIENTS 1994 ·Infectious Disease Clinics of North America ·Gerald P. Bodey	20
8	Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy 1991 ·The American Journal of Medicine ·Elias Anaissie, Gerald P. Bodey, Hagop M. Kantarjian, Cynthia L. David, (unknown), Eric J. Bow, Richard DeFelice, Nancy Downs, Thomas M. File, George A. Karam, David Potts, Mark Shelton, Alan M. Sugar	170
9	In-vitro activity of PD 117 596, a new quinolone, against bacterial isolates from cancer patients 1990 ·Journal of Antimicrobial Chemotherapy ·Kenneth V. I. Rolston, Barbara LeBlanc, (unknown), Gerald P. Bodey	11
10	Klebsiella bacteremia. A 10-year review in a cancer institution 1989 ·Cancer ·Gerald P. Bodey, Linda S. Elting, Saul Rodriguez, Martı́n Hernández	34
11	In vitro Activity of Fleroxacin (Ro23-6240), a New Fluorinated 4-Quinolone against Isolates from Cancer Patients 1988 ·Chemotherapy ·Kenneth V. I. Rolston, D H Ho, Barbara LeBlanc, Gerald P. Bodey	3
12	Cefoperazone plus mezlocillin for empiric therapy of febrile cancer patients 1988 ·The American Journal of Medicine ·Paula G. Jones, Gerald P. Bodey, Kenneth V. I. Rolston, Victor Fainstein, (unknown)	10
13	Survey of antibiotic susceptibility among gram-negative bacilli at a cancer hospital 1988 ·The American Journal of Medicine ·Gerald P. Bodey, D H Ho, (unknown)	26
14	Successful Medical Management of Neutropenic Enterocolitis in Adults With Acute Leukemia 1987 ·Southern Medical Journal ·Susan O’Brien, Hagop M. Kantarjian, Elias Anaissie, Gerald D. Dodd, Gerald P. Bodey	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact